Cargando…
Desensitization and immune tolerance induction in children with severe factor IX deficiency; inhibitors and adverse reactions to replacement therapy: a case-report and literature review
Hemophilia B is a rare X-linked recessive disorder with plasma factor IX (FIX) deficiency. 1-3% of patients treated with exogenous FIX-containing products develop inhibitors (i.e. polyclonal high affinity immunoglobulins) that neutralize the procoagulant activity of a specific coagulation factor. Al...
Autores principales: | Bon, Andrea, Morfini, Massimo, Dini, Alessandro, Mori, Francesca, Barni, Simona, Gianluca, Sottilotta, de Martino, Maurizio, Novembre, Elio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4347657/ https://www.ncbi.nlm.nih.gov/pubmed/25887512 http://dx.doi.org/10.1186/s13052-015-0116-8 |
Ejemplares similares
-
Adverse reaction to benzathine benzylpenicillin due to soy allergy: a case report
por: Barni, Simona, et al.
Publicado: (2015) -
Oral desensitization to milk: how to choose the starting dose!
por: Mori, Francesca, et al.
Publicado: (2010) -
Omalizumab and mepolizumab in the landscape of biological therapy for severe asthma in children: how to choose?
por: Giovannini, Mattia, et al.
Publicado: (2019) -
Oral Immunotherapy (OIT): A Personalized Medicine
por: Mori, Francesca, et al.
Publicado: (2019) -
From the Global Initiative for Asthma report and asthma guidelines to real-life asthma control: is there room for improvement?
por: Novembre, Elio, et al.
Publicado: (2022)